Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression

IMPORTANCE: Tranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns remain about the potential adverse effects, particularly vascular occlusive events, that may be associated with its use. OBJECTIVE: To examine the association between intravenous TXA and total thromboembolic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Surg
Autors principals: Taeuber, Isabel, Weibel, Stephanie, Herrmann, Eva, Neef, Vanessa, Schlesinger, Tobias, Kranke, Peter, Messroghli, Leila, Zacharowski, Kai, Choorapoikayil, Suma, Meybohm, Patrick
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047805/
https://ncbi.nlm.nih.gov/pubmed/33851983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2021.0884
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars